Where can I find AKRO's financial statements?

Akero Therapeutics, Inc. (AKRO)'s full income statement, balance sheet, and cash flow statement are on this page in 10-K-style line-item format. Switch between the three statements via the pill toggle above the table.

How much history is available for AKRO?

Akero Therapeutics, Inc. (AKRO) statements are available back to its earliest filed 10-K — typically 10+ years of annual data and 40 quarters of quarterly data. Free-tier users see 5 years and 8 quarters; full history unlocks with a Pro account.

How often does AKRO update its statements?

Akero Therapeutics, Inc. files a 10-K annually (full audited year-end statements) and 10-Q reports quarterly (unaudited interim statements). New filings are typically parsed and reflected on this page within 48 hours of SEC submission.

AKRO (Akero Therapeutics, Inc.) is no longer actively trading.

This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.

AKRO

Akero Therapeutics, Inc.

NASDAQ·Biotechnology · Healthcare

$54.65$0.00+0.00%

Market cap$4.50B·Market closed·Dec 9 9:00 PM UTC

USD · values shown as reported

Line item	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	Trend
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Cost of revenue	$213.00K	—	—	—	—	—
Gross profit	−$213.00K	$0.00+100.0%	$0.00	$0.00	$0.00
Research & development	$64.92M+75.2%	$81.76M+25.9%	$85.28M+4.3%	$141.80M+66.3%	$247.50M+74.5%
General & administrative	$15.24M+77.1%	$19.13M+25.5%	$29.87M+56.2%	$31.07M+4.0%	$37.93M+22.1%
SG&A (combined)	$15.24M+77.1%	$19.13M+25.5%	$29.87M+56.2%	$31.07M+4.0%	$37.93M+22.1%
Total operating expenses	$80.15M+75.6%	$100.89M+25.9%	$115.16M+14.1%	$172.87M+50.1%	$285.42M+65.1%
Operating income	−$80.15M−75.6%	−$100.89M−25.9%	−$115.16M−14.1%	−$172.87M−50.1%	−$285.42M−65.1%
Interest income	$947.00K−50.1%	$109.00K−88.5%	$3.86M+3,443.1%	$24.21M+526.9%	$38.03M+57.1%
Interest expense	—	—	$739.00K	$3.10M+319.4%	$4.67M+50.6%
Other income / (expense), net	$947.00K−50.1%	$109.00K−88.5%	$3.12M+2,765.1%	$21.11M+576.0%	$33.36M+58.0%
Income before tax	−$79.21M−81.0%	−$100.78M−27.2%	−$112.03M−11.2%	−$151.76M−35.5%	−$252.06M−66.1%
Income tax expense	−$17.00K	—	—	—	—	—
Net income	−$79.19M−81.0%	−$100.78M−27.3%	−$112.03M−11.2%	−$151.76M−35.5%	−$252.06M−66.1%

EPS (basic)	−$2.52+13.1%	−$2.89−14.7%	−$2.87+0.7%	−$2.89−0.7%	−$3.75−29.8%
EPS (diluted)	−$2.52+13.1%	−$2.89−14.7%	−$2.87+0.7%	−$2.89−0.7%	−$3.75−29.8%
Weighted avg shares (basic)	31,463,248	34,827,385	38,984,772	52,568,000	67,136,772
Weighted avg shares (diluted)	31,463,248	34,827,385	38,984,772	52,568,159	67,136,772

Depreciation & amortization	$213.00K+304.8%	$41.00K−80.8%	$43.00K+4.9%	$29.00K−32.6%	$18.00K−37.9%
EBITDA	−$78.99M−73.0%	−$100.74M−27.5%	−$111.25M−10.4%	−$148.63M−33.6%	−$247.37M−66.4%

Frequently Asked Questions About AKRO

Where can I find AKRO's financial statements?: Akero Therapeutics, Inc. (AKRO)'s full income statement, balance sheet, and cash flow statement are on this page in 10-K-style line-item format. Switch between the three statements via the pill toggle above the table.
How much history is available for AKRO?: Akero Therapeutics, Inc. (AKRO) statements are available back to its earliest filed 10-K — typically 10+ years of annual data and 40 quarters of quarterly data. Free-tier users see 5 years and 8 quarters; full history unlocks with a Pro account.
How often does AKRO update its statements?: Akero Therapeutics, Inc. files a 10-K annually (full audited year-end statements) and 10-Q reports quarterly (unaudited interim statements). New filings are typically parsed and reflected on this page within 48 hours of SEC submission.